Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_assertion description "[Subsequent progression of oligodendroglial tumors appears to be triggered by additional molecular features underlying the transition to anaplastic oligodendroglioma and glioblastoma multiforme (GBM) such as deletions of 9p and 10q, and alterations of CDKN2A (p16), which is located at 9p21.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_assertion evidence source_evidence_literature NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_assertion SIO_000772 16102584 NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_assertion wasDerivedFrom befree-20150227 NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_assertion wasGeneratedBy ECO_0000203 NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP305920.RAOOxn5qgFdGEh2B9oztj6bcj6tlUCDga1AkJyPuueIvU130_provenance.